A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -38.25% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -5.00%. Over the past 30 days, the price of CRDL has leaped by -5.00%. And in the last five days, it has surged by 14.35%.
The stock of Cardiol Therapeutics Inc (CRDL) is currently priced at $1.24. In the last session, the stock climbed significantly, topping out at $9.95 after opening at $1.24. The day’s lowest price was $7.96 before the stock closed at $1.11.
Cardiol Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $2.63 on 09/13/24, while the lowest value for the same period was recorded at $0.77 on 04/07/25.
52-week price history of CRDL Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Cardiol Therapeutics Inc’s current trading price is -53.04% away from its 52-week high, while its distance from the 52-week low is 60.20%. The stock’s price range during this period has varied between$0.77 and $2.63. The Cardiol Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.74 million for the day, a figure considerably higher than their average daily volume of 0.46 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Cardiol Therapeutics Inc (CRDL) has experienced a quarterly rise of 11.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 102.07M and boasts a workforce of 22 employees.
Cardiol Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 2 analysts are rating Cardiol Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2024, with a change in price of +0.1250. Similarly, Cardiol Therapeutics Inc recorded 373,047 in trading volume during the last 100 days, posting a change of +11.16%.
CRDL’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CRDL stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
CRDL Stock Stochastic Average
Cardiol Therapeutics Inc’s raw stochastic average for the past 50 days is presently 46.98%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 46.98%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 34.17% and 24.71%, respectively.
